STAT stories you may have missed 

Hoping to spur participation in a trial studying the role of genetics in postpartum depression, a creative agency launched an ad campaign about "Mom Genes." 

AbbVie waived all the restrictions, worldwide, on making generic copies of its Kaletra HIV pill.  

Carisma Therapeutics is hoping it can use macrophages, rather than T cells, for a cell therapy that takes aim at solid tumors. 

 Why did the U.S. change its tune on #coronavirus? What's it like to be an ICU nurse right now? And when are we getting a vaccine? Find out on STAT's podcast, the ReadoutLoud.  

At-home tests for coronavirus are here. Should you take them? 

As everyone tries to shield the elderly from the new coronavirus, "non-essential" aides are being barred from assisted living facilities where they provide care.

Preventing other Shkreli-like debacles may not save the government much money.